Fungal Biofilms: Update on Resistance - PubMed (original) (raw)
Review
Fungal Biofilms: Update on Resistance
Elisa Borghi et al. Adv Exp Med Biol. 2016.
Abstract
Over the past decade, the emergence of biofilm-related invasive fungal diseases has been the subject of numerous studies focused on antifungal resistance and its impact on antifungal therapy in severely ill patients. The majority of the studies investigated the molecular mechanisms involved in antifungal resistance and pathogenicity of biofilm production by Candida albicans and Aspergillus fumigatus, the most common etiologic agents of yeast and mold invasive infections. The main mechanism characterizing biofilm-related antifungal resistance is the production of extracellular matrix, a physical barrier preventing the drugs from entering and expressing their activity. However, over-expression of efflux pumps, genetic changes of drug targets, persister cells, biofilm-host immune system interaction, proteins leading to filamentation, all together contribute to the onset of biofilm antifungal resistance. Some of these mechanisms are shared with planktonic cells and are often related to developmental phases of biofilm formation. All physical and genetic factors leading to biofilm-related antifungal resistance have been briefly discussed.
Similar articles
- Fungal biofilm composition and opportunities in drug discovery.
Reichhardt C, Stevens DA, Cegelski L. Reichhardt C, et al. Future Med Chem. 2016 Aug;8(12):1455-68. doi: 10.4155/fmc-2016-0049. Epub 2016 Aug 3. Future Med Chem. 2016. PMID: 27485639 Review. - Fungal biofilms: From bench to bedside.
Iñigo M, Del Pozo JL. Iñigo M, et al. Rev Esp Quimioter. 2018 Sep;31 Suppl 1(Suppl 1):35-38. Rev Esp Quimioter. 2018. PMID: 30209921 Free PMC article. Review. - Tackling Fungal Resistance by Biofilm Inhibitors.
Wu S, Wang Y, Liu N, Dong G, Sheng C. Wu S, et al. J Med Chem. 2017 Mar 23;60(6):2193-2211. doi: 10.1021/acs.jmedchem.6b01203. Epub 2017 Jan 23. J Med Chem. 2017. PMID: 28051303 Review. - Strategies in the discovery of novel antifungal scaffolds.
Liu N, Wang C, Su H, Zhang W, Sheng C. Liu N, et al. Future Med Chem. 2016 Aug;8(12):1435-54. doi: 10.4155/fmc-2016-0020. Epub 2016 Jul 27. Future Med Chem. 2016. PMID: 27463376 Review.
Cited by
- Effects of Itraconazole and Micafungin on Aspergillus fumigatus Biofilms.
Liu M, Zheng H, Zeng R, Liang G, Zheng N, Liu W. Liu M, et al. Mycopathologia. 2021 Jun;186(3):387-397. doi: 10.1007/s11046-021-00534-4. Epub 2021 May 6. Mycopathologia. 2021. PMID: 33956291 - Biofilm Formed by Candida haemulonii Species Complex: Structural Analysis and Extracellular Matrix Composition.
Ramos LS, Mello TP, Branquinha MH, Santos ALS. Ramos LS, et al. J Fungi (Basel). 2020 Apr 3;6(2):46. doi: 10.3390/jof6020046. J Fungi (Basel). 2020. PMID: 32260180 Free PMC article. - Life on a leaf: the epiphyte to pathogen continuum and interplay in the phyllosphere.
Thomas G, Kay WT, Fones HN. Thomas G, et al. BMC Biol. 2024 Aug 7;22(1):168. doi: 10.1186/s12915-024-01967-1. BMC Biol. 2024. PMID: 39113027 Free PMC article. Review. - Natural Anti-biofilm Agents: Strategies to Control Biofilm-Forming Pathogens.
Mishra R, Panda AK, De Mandal S, Shakeel M, Bisht SS, Khan J. Mishra R, et al. Front Microbiol. 2020 Oct 29;11:566325. doi: 10.3389/fmicb.2020.566325. eCollection 2020. Front Microbiol. 2020. PMID: 33193155 Free PMC article. Review. - Comparative analysis of the biological characteristics and mechanisms of azole resistance of clinical Aspergillus fumigatus strains.
Zeng M, Zhou X, Yang C, Liu Y, Zhang J, Xin C, Qin G, Liu F, Song Z. Zeng M, et al. Front Microbiol. 2023 Nov 9;14:1253197. doi: 10.3389/fmicb.2023.1253197. eCollection 2023. Front Microbiol. 2023. PMID: 38029222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous